Skip to main content

Year: 2025

Flutter Entertainment announces completion of Boyd agreement to secure 100% ownership of FanDuel

DUBLIN and TORONTO, July 31, 2025 (GLOBE NEWSWIRE) — Flutter Entertainment (“Flutter”) (NYSE:FLUT, LSE:FLTR), the leading online sports betting and iGaming operator, today announces that it has completed the extension of its long-term strategic partnership with Boyd Gaming Corporation to 2038 and the buyout of Boyd’s 5% stake in FanDuel Group. As previously announced the market access savings secured as part of the transaction will be effective July 1, 2025. About Flutter Entertainment plc Flutter is the world’s leading online sports betting and iGaming operator, a market leading position in the US and across the world. Our ambition is to leverage our size and our challenger mindset to change our industry for the better. By Changing the Game, we believe we can deliver long-term growth while promoting a positive, sustainable...

Continue reading

Hepsiburada Announces Second Quarter 2025 Financial Results

ISTANBUL, July 31, 2025 (GLOBE NEWSWIRE) — D-MARKET Electronic Services & Trading (d/b/a “Hepsiburada”) (NASDAQ: HEPS), a leading Turkish e-commerce platform (referred to herein as “Hepsiburada” or the “Company”), today announces its unaudited financial results for the second quarter and the six months ended June 30, 2025. Restatement of financial information: Pursuant to the International Accounting Standard 29, Financial Reporting in Hyperinflationary Economies (“IAS 29”), the financial statements of entities whose functional currency is that of a hyperinflationary economy must be adjusted for the effects of changes in a general price index. Turkish companies reporting under International Financial Reporting Standards (“IFRS”), including the Company, have been required to apply IAS 29 to their financial statements for periods...

Continue reading

Itron Announces Second Quarter 2025 Financial Results

LIBERTY LAKE, Wash., July 31, 2025 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating the way utilities and cities manage energy and water, announced today financial results for its second quarter ended June 30, 2025. Key results for the quarter include (compared with the second quarter of 2024):Revenue of $607 million; Gross profit of $224 million, increased 6%; GAAP net income attributable to Itron, Inc. of $68 million, increased $17 million; GAAP diluted earnings per share of $1.47, increased $0.37 per share; Non-GAAP diluted EPS of $1.62, increased $0.41 per share; Adjusted EBITDA of $90 million, increased 16%; and Free cash flow of $91 million, increased $46 million.“Itron delivered solid second quarter results driving quarterly record levels of margin, profitability, and cash flow,” said Tom...

Continue reading

InterDigital Announces Financial Results for Second Quarter 2025

Samsung arbitration decision and new HP license agreement drive Q2 results, exceeding outlookAnnualized recurring revenue1, at all-time high of $553 million, up 44% YoYCompany raises full year 2025 revenue guidance by $110 million WILMINGTON, Del., July 31, 2025 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video, and AI technology research and development company, today announced results for the quarter ended June 30, 2025.Revenue of $300.6 million, up 34% year-over-year, driven by the conclusion of the Samsung arbitration and the new license agreement with HP. Net income was $180.6 million and diluted EPS was $5.35, up year-over-year 65% and 36%, respectively. Non-GAAP EPS2 at all-time high of $6.52 and Adjusted EBITDA3 of $236.7 million.“Our agreement with Samsung is the largest license InterDigital...

Continue reading

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

JUPITER, Fla., July 31, 2025 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic” or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional input proteins for use in life sciences, food and nutrition, and industrial biotechnology applications utilizing its proprietary gene expression platforms, today announced the pricing of its previously announced underwritten public offering of 6,052,000 shares of common stock at a public offering price of $0.95 per share. The Company expects the gross proceeds from this offering to be approximately $5.75 million, before deducting the underwriting discount and other offering expenses. Closing of the offering is expected to occur on August 1, 2025, subject to customary closing conditions. Craig-Hallum...

Continue reading

Fortis Inc. Announces Third Quarter Dividends – 2025

ST. JOHN’S, Newfoundland and Labrador, July 31, 2025 (GLOBE NEWSWIRE) — This news release constitutes a “Designated News Release” incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis’ short form base shelf prospectus dated December 9, 2024. The Board of Directors of Fortis Inc. (“Fortis” or the “Corporation”) (TSX/NYSE: FTS) has declared the following dividends payable on September 1, 2025 to the Shareholders of Record of the following Shares of the Corporation at the close of business on August 19, 2025:$0.3063 per share on the First Preference Shares, Series “F”;$0.3826875 per share on the First Preference Shares, Series “G”;$0.26144 per share on the First Preference Shares, Series “H”;$0.258545 per share...

Continue reading

Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics

Acquisition strengthens Supernus’ leading presence in neuropsychiatric conditions with an innovative commercial product, ZURZUVAE® (zuranolone), and a novel CNS discovery platform, accelerating mid- to long-term revenue and cash flow growth and further diversifying revenue base ROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) (“Supernus”) today announced that it has successfully completed its previously announced acquisition of Sage Therapeutics, Inc. (Nasdaq: SAGE) (“Sage”). “Sage is an ideal fit in our corporate development strategy, adding a significant fourth growth product to our portfolio and further diversifying our sources of future revenue,” said Jack Khattar, President and CEO of Supernus Pharmaceuticals. “With our proven track record of strong commercial execution along with...

Continue reading

Cohen & Company Reports Second Quarter 2025 Financial Results

Second Quarter 2025 Revenue of $59.9 Million Second Quarter 2025 Net Income Attributable to Cohen & Company Inc. of $1.4 Million, or $0.81 per Diluted Share Second Quarter 2025 Adjusted Pre-Tax Income of $5.5 Million, or $0.94 per Diluted Share Board Declares Quarterly Dividend of $0.25 per Share PHILADELPHIA and NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — Cohen & Company Inc. (NYSE American: COHN), a financial services firm specializing in an expanding range of capital markets and asset management services, today reported financial results for its second quarter ended June 30, 2025. Summary Operating Results      Three Months Ended   Six Months Ended($ in thousands) 6/30/25   3/31/25   6/30/24   6/30/25   6/30/24                   Net trading $ 10,757     $ 9,211     $ 8,798     $ 19,968     $ 18,646  Asset...

Continue reading

Hiab has closed the sale of MacGregor

HIAB CORPORATION, PRESS RELEASE, 31 JULY 2025 AT 3:00 PM (EEST) Hiab has closed the sale of MacGregor Hiab (at the time Cargotec) announced on 14 November 2024 that it had signed an agreement to sell its MacGregor business to funds managed by Triton (“Triton”). (“the Transaction”) On 1 July, Hiab announced that regulatory approvals for the sale of MacGregor had been obtained from other jurisdictions, including the European Union, but the approval from the Chinese State Administration for Market Regulation (SAMR) was still pending. Hence, the closing of the Transaction was expected by 1 October 2025, later than initially expected 1 July 2025. On 10 July 2025, Hiab announced that all regulatory approvals had been secured, and the closing of the Transaction was expected on 31 July 2025. Triton has today transferred the agreed purchase price...

Continue reading

DT Midstream Reports Strong Second Quarter 2025 Results

DETROIT, July 31, 2025 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) today announced second quarter 2025 reported net income of $107 million, or $1.04 per diluted share. For the second quarter of 2025, Operating Earnings were also $107 million, or $1.04 per diluted share. Adjusted EBITDA for the quarter was $277 million. Reconciliations of Operating Earnings and Adjusted EBITDA (non-GAAP measures) to reported net income are included at the end of this news release. The company also announced that the DT Midstream Board of Directors declared a $0.82 per share dividend on its common stock payable October 15, 2025 to stockholders of record at the close of business September 15, 2025. “We had another strong quarter, and the business is performing on track with our full-year plan,” said David Slater, President and CEO. “We continue...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.